SCHEMBL7904464

SCHEMBL7904464

COC(=O)[C@H](C)NC(=O)c1cc(C(F)(F)F)cc([N+](=O)[O-])c1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
MAPT P10636 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
MEN1 O00255 1/20 0.42
PKM P14618 1/20 0.42
KMT2A Q03164 1/20 0.42
P2RX1 P51575 2/20 0.40
KCNMA1 Q12791 1/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
HIF1A Q16665 1/20 0.40
TXNRD1 Q16881 1/20 0.40
TXNRD3 Q86VQ6 1/20 0.40
TXNRD2 Q9NNW7 1/20 0.40
LMNA P02545 3/20 0.39
GAA P10253 1/20 0.39
PLK1 P53350 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9311405 0.89 ALDH1A1 (0.50) ALDH1A1MAPTTDP1MEN1PKM
SCHEMBL9311399 0.89 ALDH1A1 (0.50) ALDH1A1MAPTTDP1MEN1PKM
SCHEMBL7905583 0.84 CFTR (0.45) ALDH1A1P2RX1HPGDMAPK1
SCHEMBL7908193 0.77 GLA (0.55) ALDH1A1MEN1KMT2AKCNMA1CYP3A4
SCHEMBL7903545 0.76 ALDH1A1 (0.64) ALDH1A1MAPTTDP1MEN1KMT2A
SCHEMBL31113950 0.73 NPSR1 (0.54) P2RX1CYP3A4GAAMAPK1
SCHEMBL7904472 0.72 ALDH1A1 (0.49) ALDH1A1MAPTTDP1MEN1PKM
SCHEMBL7904468 0.72 ALDH1A1 (0.49) ALDH1A1MAPTTDP1MEN1PKM
SCHEMBL9015339 0.72 ALDH1A1 (0.82) ALDH1A1MAPTTDP1CYP3A4HPGD
SCHEMBL9310492 0.71 EGLN1 (0.46) ALDH1A1P2RX1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201119-B1 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-13 US disclosed